What this Trial Is About

Colorectal cancer is the second most common cancer in European Union countries. Colonoscopy is the main method used to detect and prevent colorectal cancer by identifying and removing precancerous lesions like adenomas and serrated polyps. This study investigates how artificial intelligence (AI) might improve the detection rate of polyps and early colorectal cancer stages during colonoscopy procedures. The study uses an AI-assisted device called the Endo-Aid CADe system, which helps endoscopists by recognizing suspicious lesions in real time during colonoscopy. The system processes images from the colonoscopy and highlights potential polyps on the monitor to assist detection. Participants undergo standard outpatient colonoscopy with or without this AI device to compare outcomes. Participants are adults aged 50 to 65 scheduled for outpatient colonoscopy. During the study, researchers will monitor how often adenomas are detected using the AI system compared to usual care. The primary measurement is the adenoma detection rate during colonoscopy. The study excludes those with previous colonoscopy, colorectal surgery, certain inflammatory bowel diseases, or ongoing biological therapy. Consent to participate is required.

Artificial Intelligence in Colonoscopy